US Insurers Extend Routine Vaccine Coverage Through 2027 as Measles Cases Near 2,000
Updated
Updated · The Guardian · Jun 7
US Insurers Extend Routine Vaccine Coverage Through 2027 as Measles Cases Near 2,000
1 articles · Updated · The Guardian · Jun 7
Summary
AHIP said member insurers will keep covering routine vaccines through 2027, extending a 2026 policy after court action paused disputed federal vaccine-panel changes.
Nearly 2,000 measles cases this year and record-high whooping cough rates last year have sharpened the financial and public-health case for coverage, with experts saying insurers know vaccination costs less than hospitalization.
The extension comes as Donald Trump ordered a review of the childhood immunization schedule, following a December memo and broader pressure on vaccine recommendations under Health Secretary Robert F. Kennedy Jr.
Lawyers in the pediatricians' lawsuit said the order has limited immediate legal effect, but could help the administration reconvene the stalled advisory committee; any move resembling January's one-third cut in recommendations would violate the judge's order.
Experts said the insurers' stance signals confidence that vaccines are safe and effective, even as anti-vaccine moves remain politically risky ahead of the November midterms.